LIVE DATABASE v1.0
返回公司目录
COMPANY PROFILE / #2259

Kimia(Discovery Tools (Healthcare))

Berkeley, CAVenture Capital-Backed
官网
OVERVIEW

Developer of a drug discovery platform intended to cater to the areas of oncology, immunology, and inflammation. The company's platform helps apply high throughput precision chemistry in combination with genome editing and machine learning to identify drugable sites at key nodes of intervention in human disease and to generate datasets that reveal the molecular features of active and inactive drug molecules and through machine learning generate algorithms and feature maps, helping clients accelerate the discovery of drugs for novel and challenging targets.

已融资57.23
最新估值75.00
员工数35
成立年份2023

公司概况

Companies
Kimia(Discovery Tools (Healthcare))
Description
Developer of a drug discovery platform intended to cater to the areas of oncology, immunology, and inflammation. The company's platform helps apply high throughput precision chemistry in combination with genome editing and machine learning to identify drugable sites at key nodes of intervention in human disease and to generate datasets that reveal the molecular features of active and inactive drug molecules and through machine learning generate algorithms and feature maps, helping clients accelerate the discovery of drugs for novel and challenging targets.
HQ Location
Berkeley, CA
Year Founded
2023
Keywords
biotechnology research, chemoproteomics technology, drug discovery engine, medicine maker, precision product, transcriptomics data analysis
Competitors
Maze Therapeutics, Eikon Therapeutics
Ownership Status
Privately Held (backing)
Company Financing Status
Venture Capital-Backed

融资与估值

Total Raised
57.23
First Financing Date
01-Jan-2023
First Financing Size
First Financing Valuation
Last Financing Date
19-Dec-2023
Last Financing Deal Type
Early Stage VC
Last Financing Size
55.00
Last Financing Valuation
75.00
Last Financing Status
Completed
Last Known Valuation
75.00
Last Known Valuation Date
19-Dec-2023
Last Known Valuation Deal Type
Early Stage VC
Valuation Estimate
117.96
Valuation Estimate Growth Rate
57.28%
Active Investors
Dimension (United States), Horizons Ventures, The Column Group
# Active Investors
3
Acquirers

团队与联系人

Employees
35
Employee Growth %
12.90%
Employee History
2025: 35, 2024: 31, 2023: 16
Primary Contact
Stig Hansen
Primary Contact Title
Co-Founder, Chief Executive Officer, Board Member and President
Primary Contact Email
shansen@kimiatx.com
Primary Contact Phone

增长与经营

Revenue
Revenue Growth %
Growth Rate
0.00%
Growth Rate % Change
Growth Rate Percentile
13
Size Multiple
2.85x
Size Multiple % Change
0.00%
Size Multiple Change
0.00x
Size Multiple Percentile
74
Majestic Referring Domains
74
SimilarWeb Unique Visitors
293
SimilarWeb Unique Visitors Change
15
SimilarWeb Growth Rate
SimilarWeb Growth Rate Percentile
Success Probability Over Time – 1 Year
8%
Success Probability Over Time – 3 Year
23%
Success Probability Over Time – 5 Year
35%
记录来源:public.companies · 原始序号 #2259 · 所有字段均按数据库原值展示。